A new model system swims into focus: Using the zebrafish to visualize intestinal lipid metabolism in vivo

Future Lipidology

Volumn 4, Issue 4, 2009, Pages 501-515

  Carten, Juliana D ^a   Farber, Steven A ^a  

^a GEOPHYSICAL LABORATORY   (United States)

Author keywords

BODIPY; Fatty acids; Genetics; Intestine; Zebrafish

Indexed keywords

ALLI; DYE; EZETIMIBE; MICROSPHERE; PHOSPHOLIPASE; PROTEINASE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

DIGESTIVE FUNCTION; DRUG MECHANISM; DYSLIPIDEMIA; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GASTROINTESTINAL MOTILITY; GENETIC CONSERVATION; GENETIC SCREENING; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; INTESTINE; LARVA; LIPID METABOLISM; LIPOPHILICITY; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; REVIEW; VERTEBRATE; ZEBRA FISH;

DANIO RERIO; MUS;

EID: 69549110658     PISSN: 17460875     EISSN: None     Source Type: Journal    
DOI: 10.2217/CLP.09.40     Document Type: Review

References (100)

1. Joffe BI, Panz VR, Raal FJ: From lipodystrophy syndromes to diabetes mellitus. Lancet 357(9266), 1379-1381 (2001).
2. McNeely MJ, Edwards KL, Marcovina SM, Brunzell JD, Motulsky AG, Austin MA: Lipoprotein and apolipoprotein abnormalities in familial combined hyperlipidemia: a 20-year prospective study. Atherosclerosis 159(2), 471-481 (2001).
3. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A: Liver diseases and metabolic syndrome. J. Gastroenterol. 43(7), 509-518 (2008).
4. Wang Y, Beydoun MA: The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic Rev. 29, 6-28 (2007).
5. Ford ES, Mokdad AH: Epidemiology of obesity in the Western Hemisphere. J. Clin. Endocrinol. Metab. 93(11 Suppl. 1), S1-S8 (2008).
6. Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab. 93(11 Suppl. 1), S9-S30 (2008).
7. Van Heek M, France CF, Compton DS et al.: In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J. Pharmacol. Experimen. Therap. 283(1), 157-163 (1997).
8. Farber SA, Pack M, Ho SY et al.: Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science 292(5520), 1385-1388 (2001).
9. Hama K, Provost E, Baranowski TC et al.: In vivo imaging of zebrafish digestive organ function using multiple quenched fluorescent reporters. Am. J. Physiol. Gastrointest. Liver Physiol. 296(2), G445-G453 (2009).
10. Field HA, Kelley KA, Martell L, Goldstein AM, Serluca FC: Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterol. Motil. 21(3), 304-312 (2009).
11. Coleman RA, Lee DP: Enzymes of triacylglycerol synthesis and their regulation. Prog. Lipid Res. 43(2), 134-176 (2004).
12. Rousset M: The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 68(9), 1035-1040 (1986).
13. Trotter PJ, Storch J: Fatty acid esterification during differentiation of the human intestinal cell line Caco-2. J. Biol. Chem. 268(14), 10017-10023 (1993).
14. Field FJ: Regulation of intestinal cholesterol metabolism. In: Intestinal Lipid Metabolism. Mansbach CM, Tso P, Kuksis A (Eds). Kluwer Academic, NY, USA 235-255 (2001).
15. Moschetta A, Xu F, Hagey LR et al.: A phylogenetic survey of biliary lipids in vertebrates. J. Lipid Res. 46(10), 2221-2232 (2005).
16. Pack M, Solnica-Krezel L, Malicki J et al.: Mutations affecting development of zebrafish digestive organs. Development 123, 321-328 (1996).
17. Kruit JK, Groen AK, van Berkel TJ, Kuipers F: Emerging roles of the intestine in control of cholesterol metabolism. World J. Gastroenterol. 12(40), 6429-6439 (2006).
18. Tian WX: Inhibition of fatty acid synthase by polyphenols. Curr. Med. Chem. 13(8), 967-977 (2006).
19. Martin FP, Wang Y, Sprenger N et al.: Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 4, 157 (2008).
20. Yutzey KE, Robbins J: Principles of genetic murine models for cardiac disease. Circulation 115(6), 792-799 (2007).
21. Masucci-Magoulas L, Plump A, Jiang XC, Walsh A, Breslow JL, Tall AR: Profound induction of hepatic cholesteryl ester transfer protein transgene expression in apolipoprotein E and low density lipoprotein receptor gene knockout mice. A novel mechanism signals changes in plasma cholesterol levels. J. Clin. Investig. 97(1), 154-161 (1996).
22. Anstee QM, Goldin RD: Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol. 87(1), 1-16 (2006).
23. Carroll L, Voisey J, van Daal A: Mouse models of obesity. Clin. Dermatol. 22(4), 345-349 (2004).
24. Fishman MC: Genomics. Zebrafish - the canonical vertebrate. Science 294(5545), 1290-1291 (2001).
25. Amali AA, Rekha RD, Lin CJ et al.: Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis. J. Biomed. Sci. 13(2), 225-232 (2006).
26. Bai Q, Mullett SJ, Garver JA, Hinkle DA, Burton EA: Zebrafish DJ-1 is evolutionarily conserved and expressed in dopaminergic neurons. Brain Res. 1113(1), 33-44 (2006).
27. Berghmans S, Murphey RD, Wienholds E et al.: Tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl Acad. Sci. USA 102(2), 407-412 (2005).
28. Fetcho JR: The utility of zebrafish for studies of the comparative biology of motor systems. J. Exp. Zoolog. B. Mol. Dev. Evol. 308(5), 550-562 (2006).
29. Fisher S, Jagadeeswaran P, Halpern ME: Radiographic analysis of zebrafish skeletal defects. Dev. Biol. 264(1), 64-76 (2003).
30. Guyon JR, Steffen LS, Howell MH, Pusack TJ, Lawrence C, Kunkel LM: Modeling human muscle disease in zebrafish. Biochim. Biophys. Acta 1772(2), 205-215 (2007).
31. Khuchua Z, Yue Z, Batts L, Strauss AW: A zebrafish model of human Barth syndrome reveals the essential role of tafazzin in cardiac development and function. Circ. Res. 99(2), 201-208 (2006).
32. Kunkel LM, Bachrach E, Bennett RR, Guyon J, Steffen L: Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish. J. Hum. Gen. 51(5), 397-406 (2006).
33. Lam SH, Gong Z: Modeling liver cancer using zebrafish: a comparative oncogenomics approach. Cell Cycle 5(6), 573-577 (2006).
34. Lam SH, Wu YL, Vega VB et al.: Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression. Nat. Biotechnol. 24(1), 73-75 (2006).
35. Langenau DM, Zon LI: The zebrafish: a new model of T-cell and thymic development. Nat. Rev. Immunol. 5(4), 307-317 (2005).
36. Langheinrich U, Vacun G, Wagner T: Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia. Toxicol. Appl. Pharmacol. 193(3), 370-382 (2003).
37. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, Rubinstein AL: Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons. Brain Res. Mol. Brain Res. 141(2), 128-137 (2005).
38. Norrby K: In vivo models of angiogenesis. J. Cell Mol. Med. 10(3), 588-612 (2006).
39. Obara T, Mangos S, Liu Y et al.: Polycystin-2 immunolocalization and function in zebrafish. J. Am. Soc. Nephrol. 17(10), 2706-2718 (2006).
40. Sabaawy HE, Azuma M, Embree LJ, Tsai HJ, Starost MF, Hickstein DD: TEL-AML1 transgenic zebrafish model of precursor B cell acute lymphoblastic leukemia. Proc. Natl Acad. Sci. USA 103(41), 15166-15171 (2006).
41. Sayer JA, Otto EA, O'Toole JF et al.: The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4. Nat. Genet. 38(6), 674-681 (2006).
42. Titus TA, Selvig DR, Qin B et al.: The Fanconi anemia gene network is conserved from zebrafish to human. Gene 371(2), 211-223 (2006).
43. Williamson KA, Hever AM, Rainger J et al.: Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum. Mol. Gen. 15(9), 1413-1422 (2006).
44. Matthews RP, Lorent K, Manoral-Mobias R et al.: TNFα-dependent hepatic steatosis and liver degeneration caused by mutation of zebrafish S-adenosylhomocysteine hydrolase. Development 136(5), 865-875 (2009).
45. Chico TJ, Ingham PW, Crossman DC: Modeling cardiovascular disease in the zebrafish. Trends Cardiovasc. Med. 18(4), 150-155 (2008).
46. Sadler KC, Amsterdam A, Soroka C, Boyer J, Hopkins N: A genetic screen in zebrafish identifies the mutants vps18, nf2 and foie gras as models of liver disease. Development 132(15), 3561-3572 (2005).
47. Parsons MJ, Campos I, Hirst EM, Stemple DL: Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development 129(14), 3505-3512 (2002).
48. Feitsma H, Cuppen E: Zebrafish as a cancer model. Mol. Cancer Res. 6(5), 685-694 (2008).
49. Stainier DY, Weinstein BM, Detrich HW 3rd, Zon LI, Fishman MC: Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Nat. Genet. 20(3), 244-250 (1998).
50. Song Y, Cone RD: Creation of a genetic model of obesity in a teleost. FASEB J. 21(9), 2042-2049 (2007).
51. Barbazuk WB, Korf I, Kadavi C et al.: The syntenic relationship of the zebrafish and human genomes. Genome Res. 10(9), 1351-1358 (2000).
52. Lander ES, Linton LM, Birren B et al.: Initial sequencing and analysis of the human genome. Nature 409(6822), 860-921 (2001).
53. Postlethwait J, Amores A, Force A, Yan Y: The zebrafish genome. Methods Cell Biol. 60, 149-163 (1999).
54. Postlethwait JH, Yan YL, Gates MA et al.: Vertebrate genome evolution and the zebrafish gene map. Nat. Genet. 18(4), 345-349 (1998).
55. Farber SA, De Rose RA, Olson ES, Halpern ME: The zebrafish annexin gene family. Genome Res. 13(6A), 1082-1096 (2003).
56. Stainier DY, Weinstein BM, Detrich HW 3rd, Zon LI, Fishman MC: Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development 121(10), 3141-3150 (1995).
57. Wallace K, Pack M: Unique and conserved aspects of gut development in zebrafish. Dev. Biol. 255(1), 12-29 (2003).
58. Yee NS, Yusuff S, Pack M: Zebrafish pdx1 morphant displays defects in pancreas development and digestive organ chirality, and potentially identifies a multipotent pancreas progenitor cell. Genesis 30(3), 137-140 (2001).
59. Wallace KN, Yusuff S, Sonntag JM, Chin AJ, Pack M: Zebrafish hhex regulates liver development and digestive organ chirality. Genesis 30(3), 141-143 (2001).
60. Flynn EJ 3rd, Trent CM, Rawls JF: Ontogeny and nutritional control of adipogenesis in zebrafish (Danio rerio). J. Lipid Res. DOI: 10.1194/jlr.M800590-JLR200 (2009) (Epub ahead of print).
61. Lin JW, Biankin AV, Horb ME et al.: Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev. Biol. 270(2), 474-486 (2004).
62. Sheridan MA: Lipid dynamics in fish: aspects of absorption, transportation, deposition and mobilization. Comp. Biochem. Physio. B 90(4), 679-690 (1988).
63. Grosser T, Yusuff S, Cheskis E, Pack MA, FitzGerald GA: Developmental expression of functional cyclooxygenases in zebrafish. Proc. Natl Acad. Sci. USA 99(12), 8418-8423 (2002).
64. Babin PJ, Thisse C, Durliat M, Andre M, Akimenko MA, Thisse B: Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc. Natl Acad. Sci. USA 94(16), 8622-8627 (1997).
65. Bownes M: Why is there sequence similarity between insect yolk proteins and vertebrate lipases? J. Lipid Res. 33(6), 777-790 (1992).
66. Munoz G, Donghi S, Cerisola H: Vitellogenesis in the crayfish Rhynchocinetes typus: role of hepatopancreas in lipid yolk biosynthesis. Cell. Mol. Biol. 36(5), 531-536 (1990).
67. Marza E, Barthe C, Andre M, Villeneuve L, Helou C, Babin PJ: Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit. Dev. Dyn. 232(2), 506-518 (2005).
68. Spence R, Fatema MK, Ellis S, Ahmed ZF, Smith C: Diet, growth and recruitment of wild zebrafish in Bangladesh. J. Fish Biol. 71(1), 304-309 (2007).
69. Enzler L, Smith V, Lin JS, Olcott HS: Lipids of Mono Lake, California, brine shrimp (Artemia salina). J. Agricul. Food Chem. 22(2), 330-331 (1974).
70. Thomson AB, Schoeller C, Keelan M, Smith L, Clandinin MT: Lipid absorption: passing through the unstirred layers, brush-border membrane, and beyond. Can. J. Physiol. Pharmacol. 71(8), 531-555 (1993).
71. Layer P, Keller J: Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J. Clin. Gastroenterol. 28(1), 3-10 (1999).
72. Brasaemle DL: Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48(12), 2547-2559 (2007).
73. Cases S, Smith SJ, Zheng YW et al.: Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl Acad. Sci. USA 95(22), 13018-13023 (1998).
74. Cases S, Stone SJ, Zhou P et al.: Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276(42), 38870-38876 (2001).
75. Targett-Adams P, Chambers D, Gledhill S et al.: Live cell analysis and targeting of the lipid droplet-binding adipocyte differentiation-related protein. J. Biol. Chem. 278(18), 15998-16007 (2003).
76. Novikoff AB, Novikoff PM, Rosen OM, Rubin CS: Organelle relationships in cultured 3T3-L1 preadipocytes. J. Cell Biol. 87(1), 180-196 (1980).
77. Bartz R, Li WH, Venables B et al.: Lipidomics reveals that adiposomes store ether lipids and mediate phospholipid traffic. J. Lipid Res. 48(4), 837-847 (2007).
78. Goodman JM: The gregarious lipid droplet. J. Biol. Chem. 283(42), 28005-28009 (2008).
79. Samson-Bouma ME, Verthier N, Ginsel LA, Feldmann G, Fransen JA, Aggerbeck LP: Ultrastructural immunogold labeling of lipid-laden enterocytes from patients with genetic malabsorption syndromes. Biol. Cell 87(3), 189-196 (1996).
80. Gordon DA, Wetterau JR, Gregg RE: Microsomal triglyceride transfer protein: a protein complex required for the assembly of lipoprotein particles. Trends Cell Biol. 5(8), 317-321 (1995).
81. Schlegel A, Stainier DY: Microsomal triglyceride transfer protein is required for yolk lipid utilization and absorption of dietary lipids in zebrafish larvae. Biochemistry 45(51), 15179-15187 (2006).
82. Fukumoto S, Fujimoto T: Deformation of lipid droplets in fixed samples. Histochem. Cell Biol. 118(5), 423-428 (2002).
83. Greenspan P, Mayer EP, Fowler SD: Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100(3), 965-973 (1985).
84. Fowler SD, Greenspan P: Application of Nile red, a fluorescent hydrophobic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J. Histochem. Cytochem. 33(8), 833-836 (1985).
85. Carlson LA: Studies on the effect of nicotinic acid on catecholamine stimulated lipolysis in adipose tissue in vitro. Acta Medica Scandinavica 173, 719-722 (1963).
86. Jones KS, Alimov AP, Rilo HL, Jandacek RJ, Woollett LA, Penberthy WT: A high throughput live transparent animal bioassay to identify non-toxic small molecules or genes that regulate vertebrate fat metabolism for obesity drug development. Nut. Metab. 5, 23 (2008).
87. Sandoval A, Fraisl P, Arias-Barrau E et al.: Fatty acid transport and activation and the expression patterns of genes involved in fatty acid trafficking. Arch. Biochem. Biophysics 477(2), 363-371 (2008).
88. Treibs A, Kreuzer F-H: Difluorboryl-komplexe von di- und tripyrrylmethenen. Liebigs Ann. Chem. 718, 208-223 (1968).
89. Boldyrev IA, Zhai X, Momsen MM, Brockman HL, Brown RE, Molotkovsky JG: New BODIPY lipid probes for fluorescence studies of membranes. J. Lipid Res. 48(7), 1518-1532 (2007).
90. Hendrickson HS, Hendrickson EK, Johnson ID, Farber SA: Intramolecularly quenched BODIPY-labeled phospholipid analogs in phospholipase A2 and platelet-activating factor acetylhydrolase assays and in vivo fluorescence imaging. Anal. Biochem. 276(1), 27-35 (1999).
91. 2+-dependent phospholipase A2 activity during zebrafish embryogenesis. J. Biol. Chem. 274(27), 19338-19346 (1999).
92. Ho SY, Lorent K, Pack M, Farber SA: Zebrafish fat-free is required for intestinal lipid absorption and Golgi apparatus structure. Cell. Metab. 3(4), 289-300 (2006).
93. Watanabe T, Asaka S, Kitagawa D et al.: Mutations affecting liver development and function in Medaka, Oryzias latipes, screened by multiple criteria. Mech. Dev. 121(7-8), 791-802 (2004).
94. Bolcome RE 3rd, Sullivan SE, Zeller R, Barker AP, Collier RJ, Chan J: Anthrax lethal toxin induces cell death-independent permeability in zebrafish vasculature. Proc. Natl Acad. Sci. USA 105(7), 2439-2444 (2008).
95. Jones LJ, Upson RH, Haugland RP, Panchuk-Voloshina N, Zhou M, Haugland RP: Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement. Anal. Biochem. 251(2), 144-152 (1997).
96. Menges DA, Ternullo DL, Tan-Wilson AL, Gal S: Continuous assay of proteases using a microtiter plate fluorescence reader. Anal. Biochem. 254(1), 144-147 (1997).
97. Sarment DP, Korostoff J, D'Angelo M, Polson AM, Feldman RS, Billings PC: In situ localization and characterization of active proteases in chronically inflamed and healthy human gingival tissues. J. Periodontol. 70(11), 1303-1312 (1999).
98. Raybould HE: Mechanisms of CCK signaling from gut to brain. Curr. Opin. Pharmacol. 7(6), 570-574 (2007).
99. Haffter P, Granato M, Brand M et al.: The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 123, 1-36 (1996).
100. Field HA, Kelley KA, Martell L, Goldstein AM, Serluca FC: Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterol. Motil. 21(3), 304-312 (2009).